Beta-Catenin in Human Colorectal Cancer
Author Information
Author(s): T Takayama, H Shiozaki, Y Doki, H Oka, M Inoue, M Yamamoto, S Tamura, S Shibamoto, F Ito, M Monden
Primary Institution: Osaka University Medical School
Hypothesis
The study investigates the expression and phosphorylation of beta-catenin in human colorectal cancer and its correlation with clinicopathological factors.
Conclusion
Reduced expression of beta-catenin is significantly correlated with tumor invasion and metastasis in colorectal cancer tissues.
Supporting Evidence
- Reduced expression of beta-catenin was observed in 33% of colon cancer tissues.
- Reduced beta-catenin expression correlated with dedifferentiation and advanced Duke's stages.
- Beta-catenin phosphorylation was more frequent in cancerous tissues than in normal mucosa.
Takeaway
This study found that in colorectal cancer, lower levels of a protein called beta-catenin are linked to more aggressive cancer behavior.
Methodology
The study used immunohistochemistry to analyze beta-catenin, E-cadherin, and alpha-catenin expression in colorectal cancer tissues.
Participant Demographics
Patients with colorectal cancer who underwent surgery at Osaka University.
Statistical Information
P-Value
<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website